{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007315","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.176543+00:00","generated_at":"2026-06-10T05:26:04.084198+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Cosmos Health receives Nasdaq reprimand for prior shareholder approval violation; matter closed","bullets":["Nasdaq issued a Letter of Reprimand on Sept 27, 2023, for failing to obtain prior shareholder approval for October 2022 public offering.","Offering involved units of common stock and warrants at a discount exceeding Nasdaq minimum price rules.","Company stated violation was inadvertent; 98% of votes at Dec 2022 meeting were affirmative had approval been sought.","Shareholder ratification obtained at Sept 18, 2023 annual meeting; no further action required.","Nasdaq noted no prior pattern of non-compliance; matter considered closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007315","json":"https://secwatch.observer/filing/0001477932-23-007315.json","markdown":"https://secwatch.observer/filing/0001477932-23-007315.md","text":"https://secwatch.observer/filing/0001477932-23-007315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007315/0001477932-23-007315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007315/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T05:26:04.084198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81dd038b13f0d563eeee6a9e075b5e42f8965e4c","claim":"Cosmos Health Inc. received a nasdaq other notice regarding other (rules 5810(c)(4)).","evidence_excerpt":"September 27, 2023, Cosmos Health Inc. (the “Company”) received a Letter of Reprimand from the Nasdaq Stock Market in accordance with Listing Rule 5810(c)(4). Nasdaq had previously determined that the Company had not obtained prior shareholder approval for the October 2022 best-efforts public offering involving the issuance of 20% or more of the outstanding shares at less than the minimum price. Because the offering consisted of Units of common stock, Series A Warrants and Series B Warrants it was necessary to allocate a value to the warrants which resulted in the Units being sold at a great","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007315/0001477932-23-007315-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Rules","value":"5810(c)(4)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}